CURE250117C119000
- 0.00
- 0.000.00%
Direxion Daily Healthcare Bull 3X Shares Newsroom
CMS Proposes 4.33% Increase for Medicare Advantage Plans
Weekly Buzz: CES Came and Brought the Pain? That's Unexpected
Wall Street Today: Labor Gains Hurt a Hurting Market
SpringWorks Therapeutics Jumps Amid Takeover Speculation
Catalyst Watch: Bank Earnings, Oil Updates, Powerhouse Conferences in Retail and Healthcare
Lilly Signs Licensing Deal With Mediar for IPF Drug
"Eli Lilly In Advanced Talks To Buy U.S. Cancer Biotech For Up To $2.5B; Scorpion's Drug Candidate Inhibits A Mutation That Is A Major Driver Of Breast, Gynaecological And Head And Neck Cancers" - Financial Times
UnitedHealth Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
AbbVie Unusual Options Activity For January 10
First Earnings Show Beats are Back, December Jobs Climbed but Market Falls Friday | Live Stock
HIMS Downgraded, Agilon Upgraded at Citi in 2025 Health Tech Review
On Thursday, Alchemab Therapeutics Entered A Collaboration With Eli Lilly To Discover, Develop, And Commercialize Up To Five Therapeutics For Amyotrophic Lateral Sclerosis; Alchemab Will Receive An Undisclosed Upfront Payment And Is Eligible To...
Pharma Companies Welcome New Year With 583 Drug Price Hikes so Far
Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference
Johnson & Johnson Pauses US Varipulse Procedures Amid Safety Review, Investigates Brain-Related Events
Drugs Not Selected for Medicare Price Negotiation Nearly Doubled - Report
Evaluating UnitedHealth Group Against Peers In Health Care Providers & Services Industry
Novo, Eli Lilly to Dominate Global Pharma Sales in 2025: Report
UnitedHealth Urged by Investors to Review Insurance Practices
S&P 500 Positive for 'First Five Days,' Huang Sees Decades till Quantum | Wall Street Today